Halozyme Reports Third Quarter 2015 Financial Results

Go back to Halozyme Reports Third Quarter 2015 Financial Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 109.80 +1.36 (1.25%)
Previous Close $108.44    52 Week High $18.39 
Open $107.08    52 Week Low $6.96 
Day High $110.88    P/E N/A 
Day Low $106.82    EPS $-0.58 
Volume 1,121,901